NEW YORK--Merrill Lynch last month announced the launch of Biotech Holdrs, a new security representing 20 varied biotechnology companies, including several genomics companies. The price of the security was $109.18 each when trading began November 23 on the American Stock Exchange under the symbol BBH. 4.5 million Holdrs, representing undivided beneficial ownership interest in the common stock, were initially priced at a total of more than $490 million.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.